FP253/Fludarabine

· Biotech Equity Partners Pty Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FP253/Fludarabine, covering 2011-07-11 to 2011-07-11. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer [Phase 1]